DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; August 2011 (2011-08), JOHANSSON PÄR I ET AL: "A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients.", XP002762325, Database accession no. NLM21772125 (B1)

DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; February 2012 (2012-02), JOHANSSON PÄR INGEMAR ET AL: "High circulating adrenaline levels at admission predict increased mortality after trauma.", XP002762327, Database accession no. NLM22439205 (B1)

DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; July 2010 (2010-07), WINDELOV NIS A ET AL: "Transfusion requirements and clinical outcome in intensive care patients receiving continuous renal replacement therapy: comparison of prostacyclin vs. heparin prefilter administration.", XP002762326, Database accession no. NLM20614572 (B1)

JOHANSSON P I ET AL: "Acute coagulopathy of trauma: Balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH, US, vol. 75, no. 6, 1 December 2010 (2010-12-01), pages 564-567, XP027421613, ISSN: 0306-9877, DOI: 10.1016/J.MEHY.2010.07.031 [retrieved on 2010-08-13] cited in the application (B1)

LENE HOLMVANG ET AL: "A single center, open, randomized study investigating the clinical safety and the endothelial modulating effects of a prostacyclin analog in combination with eptifibatide in patients having undergone primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction", PROSTAGLANDINS & OTHER LIPID MEDIATORS, vol. 99, no. 3-4, 1 December 2012 (2012-12-01), pages 87-95, XP055183856, ISSN: 1098-8823, DOI: 10.1016/j.prostaglandins.2012.08.002 (B1)

MICHAEL W J BOEHME ET AL: "Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results", RHEUMATOLOGY INTERNATIONAL ; CLINICAL AND EXPERIMENTAL INVESTIGATIONS, SPRINGER, BERLIN, DE, vol. 26, no. 4, 1 February 2006 (2006-02-01), pages 340-347, XP019335310, ISSN: 1437-160X, DOI: 10.1007/S00296-004-0563-9 (B1)

WO-A2-2011/134478 (B1)

SCHEEREN T ET AL: "Prostacyclin (PGI2): new aspects of an old substance in the treatment of critically ill patients", INTENSIVE CARE MEDICINE, BERLIN, DE, vol. 23, no. 2, 1 February 1997 (1997-02-01), pages 146-158, XP002594947, ISSN: 0342-4642 (B1)

WO-A1-2012/041334 (B1)

WO-A1-2012/143012 (B1)

WO-A1-2013/143548 (B1)

WO-A1-2015/074663 (B1)

WO-A2-2010/075861 (B1)

P. I. JOHANSSON ET AL: "High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, vol. 10, no. 2, 1 February 2012 (2012-02-01), pages 207-216, XP055304797, GB ISSN: 1538-7933, DOI: 10.1111/j.1538-7836.2011.04589.x (B1)